Concepedia
Statistics
Publications
26
Citations
4.7K
H-Index
21
Active since
1980
Affiliations
Pfizer (United States)(Current)
State University of New York
Memorial Sloan Kettering Cancer Center
Cornell University
Yeshiva University
Robert S. Garofalo is an author at Pfizer (United States) specializing in medicine, signal transduction, and cell biology.
Top concepts
MedicineSignal TransductionCell BiologyDevelopmental BiologyDiabetesPhysiologyBiochemistryEndocrinologyCell SignalingHealth
Publications per year
1980–2017
A Mutant <i>Drosophila</i> Insulin Receptor Homolog That Extends Life-Span and Impairs Neuroendocrine Function
Marc Tatar, A. H. Kopelman, Diane Epstein et al. · Science · 2001 · 1.6K citations
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec, John E. Bleasdale, Boris A. Chrunyk et al. · Journal of Biological Chemistry · 2010 · 889 citations · Full text
Molecular Biology, Compounds Srt2183, Molecular Research +16
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ
Robert S. Garofalo, Stephen Orena, Kristina Rafidi et al. · Journal of Clinical Investigation · 2003 · 711 citations · Full text
The Drosophila insulin receptor is required for normal growth.
Chen Chen, Jessica Jack, Robert S. Garofalo · Endocrinology · 1996 · 339 citations · Full text
Biology, Growth Factor Family, Signal Transduction +14
High-resolution dynamics of the transcriptional response to nutrition in <i>Drosophila</i>: a key role for dFOXO
Boris Gershman, Óscar Puig, Lilian Hang et al. · Physiological Genomics · 2006 · 178 citations
Key Role, Genetics, Transcript Abundance +20
1–5 of 26